The Real ID deadline has been extended multiple times since the federal government’s original implementation goal in 2008 to the final deadline of May 2025.

This wireless, battery-free wearable senses electrical differences between pigmented lesions and healthy skin, allowing for easier skin cancer screenings at home.

An artificial intelligence (AI)–enabled handheld elastic scattering spectroscopy (ESS) device improved the sensitivity for skin cancer diagnosis and management by primary care physicians (PCPs), with ...

HILL AND NC STATE IN 12. ON YOUR HEALTH NEWS, WE ARE LEARNING MORE ABOUT A WEARABLE PATCH THAT COULD HELP WITH EARLY SKIN CANCER DETECTION. OUR WANYA REESE TALKED WITH RESEARCHERS AT WAKE FOREST ...

DermaSensor is the maker of a medical device that primary care physicians can use to detect skin cancer on patients. To continue reading this content, please enable ...

Innovative Skin Cancer Detection Device Transforming Patient Care in Physician Offices Throughout U.S. The FDA Cleared, CE Marked DermaSensor device enables physicians to non-invasively provide ...

MIAMI, FL, UNITED STATES, October 2, 2025 / EINPresswire.com / -- DermaSensor Inc., a medical device technology company transforming skin cancer detection for frontline care, today announced it has ...

Researchers at Wake Forest University School of Medicine designed a flexible, chip-less, battery-free patch that is placed directly on the skin and works wirelessly with a small reader device. (Wake ...

The DermaSensor™ device is a cost-effective handheld tool that uses artificial intelligence and spectroscopy to non-invasively test skin lesions for skin cancer risk in seconds. By enabling quick and ...